Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Depreciation & Amortization (CF): 2013-2024

Historic Depreciation & Amortization (CF) for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $152.6 million.

  • Surgery Partners' Depreciation & Amortization (CF) fell 2131.47% to $39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $150.0 million, marking a year-over-year increase of 13.35%. This contributed to the annual value of $152.6 million for FY2024, which is 2921.25% up from last year.
  • Latest data reveals that Surgery Partners reported Depreciation & Amortization (CF) of $152.6 million as of FY2024, which was up 2921.25% from $118.1 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Depreciation & Amortization (CF) registered a high of $152.6 million during FY2024, and its lowest value of $94.8 million during FY2020.
  • For the 5-year period, Surgery Partners' Depreciation & Amortization (CF) averaged around $115.8 million, with its median value being $114.8 million (2022).
  • In the last 5 years, Surgery Partners' Depreciation & Amortization (CF) skyrocketed by 287.46% in 2023 and then surged by 2921.25% in 2024.
  • Annual analysis of 5 years shows Surgery Partners' Depreciation & Amortization (CF) stood at $94.8 million in 2020, then rose by 4.22% to $98.8 million in 2021, then increased by 16.19% to $114.8 million in 2022, then increased by 2.87% to $118.1 million in 2023, then grew by 29.21% to $152.6 million in 2024.
  • Its Depreciation & Amortization (CF) stands at $152.6 million for FY2024, versus $118.1 million for FY2023 and $114.8 million for FY2022.